Search - tctmd.com

Displaying 1 - 20 of 63

Sort: Relevancy | Date

Presentation TCT 2025

Renal Denervation is FDA Approved - Will it Ever Be First Line Therapy?

Presenter: David P. Lee

October 27, 2025

Presentation TCT 2025

TCT 178: Use of the AGENT Paclitaxel-Coated Balloon in the United States Shortly After FDA Approval: Early Results from the AGENT Post-Approval Study

Presenter: Christina Lalani

October 26, 2025

Presentation TCT 2025

A New FDA for a New Era: Innovation Demands Evolution!

Presenter: Michael R. Jaff

October 25, 2025

Presentation TCT 2025

ARS 16: The FDA and its Impact on MedTech Innovation

Presenter: Martin B. Leon

October 25, 2025

News Daily News

SCAI/HRS Issue First Practice Guideline for LAAO

Yael L. Maxwell

August 06, 2025

News Daily News

Inclisiran Gains Indication as Stand-alone Therapy to Reduce LDL Cholesterol

Michael O'Riordan

August 06, 2025

News Daily News

FDA Warns of Air Embolism Risk With Watchman LAAO Access Systems

Todd Neale

August 06, 2025

News Daily News

Reduced Shock Efficacy With Some Boston Scientific Defibrillation Leads

Todd Neale

August 06, 2025

News Industry News

Concept Medical Announces First Patient Enrollment in MAGICAL-SV IDE Trial, Expanding its Coronary Clinical Program Across the U.S. and Europe

August 01, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for July 2025

Caitlin E. Cox

July 31, 2025

News Daily News

Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data

L.A. McKeown

July 24, 2025

News Daily News

FDA Approves Finerenone for HF Patients With Mildly Reduced or Preserved EF

Caitlin E. Cox

July 14, 2025

News Daily News

FDA Warns of Issue with Impella Blood Pump Controllers

Todd Neale

July 02, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for June 2025

Michael O'Riordan

June 30, 2025

News Daily News

FDA Updates CV Warnings Around COVID-19 mRNA Vaccines

Michael O'Riordan

June 26, 2025

Presentation NY Valves 2025

Key Steps to Maximize Procedural Safety with the Amulet Occluder

Presenter: Rahul Sharma

June 26, 2025

Presentation NY Valves 2025

Sandwiches, Half-sandwiches, and No Sandwich: Dealing With Shallow Appendages Using the Amulet Device

Presenter: Reda Ibrahim

June 26, 2025

Presentation NY Valves 2025

Best Practices for Choosing Amulet Occluder Size for Optimal Outcomes

Presenter: Jacqueline Saw

June 26, 2025

Presentation NY Valves 2025

Recognizing When a Watchman Result is Not Good Enough: Making Sense of Shoulders, Gutters, Fabric Leaks, and Various Device Shapes

Presenter: Gagan D. Singh

June 26, 2025

Presentation NY Valves 2025

How To Determine the Optimal Transseptal Puncture Site for the Watchman Procedure

Presenter: Rodney Horton

June 26, 2025

Advertisement

Renal Denervation is FDA Approved - Will it Ever Be First Line Therapy?

TCT 178: Use of the AGENT Paclitaxel-Coated Balloon in the United States Shortly After FDA Approval: Early Results from the AGENT Post-Approval Study

A New FDA for a New Era: Innovation Demands Evolution!

ARS 16: The FDA and its Impact on MedTech Innovation

SCAI/HRS Issue First Practice Guideline for LAAO

Inclisiran Gains Indication as Stand-alone Therapy to Reduce LDL Cholesterol

FDA Warns of Air Embolism Risk With Watchman LAAO Access Systems

Reduced Shock Efficacy With Some Boston Scientific Defibrillation Leads

Concept Medical Announces First Patient Enrollment in MAGICAL-SV IDE Trial, Expanding its Coronary Clinical Program Across the U.S. and Europe

TCTMD’s Top 10 Most Popular Stories for July 2025

Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data

FDA Approves Finerenone for HF Patients With Mildly Reduced or Preserved EF

FDA Warns of Issue with Impella Blood Pump Controllers

TCTMD’s Top 10 Most Popular Stories for June 2025

FDA Updates CV Warnings Around COVID-19 mRNA Vaccines

Key Steps to Maximize Procedural Safety with the Amulet Occluder

Sandwiches, Half-sandwiches, and No Sandwich: Dealing With Shallow Appendages Using the Amulet Device

Best Practices for Choosing Amulet Occluder Size for Optimal Outcomes

Recognizing When a Watchman Result is Not Good Enough: Making Sense of Shoulders, Gutters, Fabric Leaks, and Various Device Shapes

How To Determine the Optimal Transseptal Puncture Site for the Watchman Procedure

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content